Company

Futura Medical plc

Headquarters: Guildford, United Kingdom

Employees: 13

CEO: Mr. James Henry Barder

LSE: FUM -4.41%

Market Cap

£96.8 Million

GBP as of Jan. 1, 2025

US$121.5 Million

Market Cap History

Futura Medical plc market capitalization over time

Evolution of Futura Medical plc market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Futura Medical plc

Detailed Description

Futura Medical plc, a pharmaceutical company, researches and develops pharmaceutical drugs and medical devices for the consumer healthcare markets focusing on sexual health and pain relief management. The company offers CSD500, a condom that contains erectogenic gel. It is also developing MED3000, a topical gel for the treatment of erectile dysfunction that has completed Phase III clinical trials. In addition, the company develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. The company was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Financials

Last Financial Reports Date Dec. 31, 2023
Revenue TTM £3.1 M
EBITDA £-6,833,498
Gross Profit TTM £1.8 M
Profit Margin -210.03%
Operating Margin -358.11%
Quarterly Revenue Growth %
Financial Reports & Statistics

Stocks & Indices

Futura Medical plc has the following listings and related stock indices.


Stock: LSE: FUM wb_incandescent

Stock: FSX: GYX wb_incandescent

Stock: OTC: FAMDF wb_incandescent

Details

Headquarters:

Surrey Technology Centre

40 Occam Road

Guildford, GU2 7YG

United Kingdom

Phone: 44 14 8368 5670

Fax: 44 14 8368 5671